BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bandyopadhyay S. Role of Neuron and Glia in Alzheimer's Disease and Associated Vascular Dysfunction. Front Aging Neurosci 2021;13:653334. [PMID: 34211387 DOI: 10.3389/fnagi.2021.653334] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen L, Fan Y, Zhao L, Zhang Q, Wang Z. The metal ion hypothesis of Alzheimer’s disease and the anti-neuroinflammatory effect of metal chelators. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.106301] [Reference Citation Analysis]
2 Baldassarro VA, Stanzani A, Giardino L, Calzà L, Lorenzini L. Neuroprotection and neuroregeneration: roles for the white matter. Neural Regen Res 2022;17:2376-80. [PMID: 35535874 DOI: 10.4103/1673-5374.335834] [Reference Citation Analysis]
3 Fernández-calle R, Konings SC, Frontiñán-rubio J, García-revilla J, Camprubí-ferrer L, Svensson M, Martinson I, Boza-serrano A, Venero JL, Nielsen HM, Gouras GK, Deierborg T. APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases. Mol Neurodegeneration 2022;17. [DOI: 10.1186/s13024-022-00566-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Mata-martínez E, Díaz-muñoz M, Vázquez-cuevas FG. Glial Cells and Brain Diseases: Inflammasomes as Relevant Pathological Entities. Front Cell Neurosci 2022;16:929529. [DOI: 10.3389/fncel.2022.929529] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bian Z, Liu X, Feng T, Yu H, Hu X, Hu X, Bian Y, Sun H, Tadokoro K, Takemoto M, Yunoki T, Nakano Y, Fukui Y, Morihara R, Abe K, Yamashita T. Protective Effect of Rivaroxaban Against Amyloid Pathology and Neuroinflammation Through Inhibiting PAR-1 and PAR-2 in Alzheimer's Disease Mice. J Alzheimers Dis 2022;86:111-23. [PMID: 35001892 DOI: 10.3233/JAD-215318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Schirò G, Balistreri CR. The close link between brain vascular pathological conditions and neurodegenerative diseases: Focus on some examples and potential treatments. Vascul Pharmacol 2021;142:106951. [PMID: 34942382 DOI: 10.1016/j.vph.2021.106951] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zhang H, Zhang Y, Li Y, Wang Y, Yan S, Xu S, Deng Z, Yang X, Xie H, Li J. Bioinformatics and Network Pharmacology Identify the Therapeutic Role and Potential Mechanism of Melatonin in AD and Rosacea. Front Immunol 2021;12:756550. [PMID: 34899707 DOI: 10.3389/fimmu.2021.756550] [Reference Citation Analysis]
8 Potjewyd FM, Axtman AD. Exploration of Aberrant E3 Ligases Implicated in Alzheimer's Disease and Development of Chemical Tools to Modulate Their Function. Front Cell Neurosci 2021;15:768655. [PMID: 34867205 DOI: 10.3389/fncel.2021.768655] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
9 Jeremic D, Jiménez-Díaz L, Navarro-López JD. Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review. Ageing Res Rev 2021;72:101496. [PMID: 34687956 DOI: 10.1016/j.arr.2021.101496] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 23.0] [Reference Citation Analysis]
10 Mottershead R, Ghisoni M. Horticultural therapy, nutrition and post-traumatic stress disorder in post-military veterans: developing non-pharmaceutical interventions to complement existing therapeutic approaches. F1000Res 2021;10:885. [PMID: 34621518 DOI: 10.12688/f1000research.70643.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]